Increased cytosolic calcium buffering contributes to a cellular arrhythmogenic substrate in iPSC-cardiomyocytes from patients with dilated cardiomyopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1803
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Increased cytosolic calcium buffering contributes to a cellular arrhythmogenic substrate in iPSC-cardiomyocytes from patients with dilated cardiomyopathy ; volume:117 ; number:1 ; day:2 ; month:5 ; year:2022 ; pages:1-18 ; date:12.2022
Basic research in cardiology ; 117, Heft 1 (2.5.2022), 1-18, 12.2022
- Urheber
-
Jung, Philipp
Seibertz, Fitzwilliam
Fakuade, Funsho E.
Ignatyeva, Nadezda
Sampathkumar, Shrivatsan
Ritter, Melanie
Li, Housen
Mason, Fleur E.
Ebert, Antje
Voigt, Niels
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00395-022-00912-z
- URN
-
urn:nbn:de:101:1-2022051921573900346338
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 16.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jung, Philipp
- Seibertz, Fitzwilliam
- Fakuade, Funsho E.
- Ignatyeva, Nadezda
- Sampathkumar, Shrivatsan
- Ritter, Melanie
- Li, Housen
- Mason, Fleur E.
- Ebert, Antje
- Voigt, Niels
- SpringerLink (Online service)
Ähnliche Objekte (12)
Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1
Mechanodynamics of cardiomyocytes in the context of dilated cardiomyopathy (DCM)
The impact of genotype on the cellular architecture of dilated and arrhythmogenic cardiomyopathies
Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes
Arrhythmogenic cardiomyopathy
Correction: Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes
Investigating LMNA-related dilated cardiomyopathy using human induced Pluripotent Stem Cell-derived cardiomyocytes
Online packet buffering
Modulation of electrical signal propagation in stem cell-derived cardiomyocytes as a novel model for arrhythmogenic cardiomyopathies
Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium
Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy
Pregnancy in arrhythmogenic cardiomyopathy
Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1
Mechanodynamics of cardiomyocytes in the context of dilated cardiomyopathy (DCM)
The impact of genotype on the cellular architecture of dilated and arrhythmogenic cardiomyopathies
Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes
Arrhythmogenic cardiomyopathy
Correction: Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes
Investigating LMNA-related dilated cardiomyopathy using human induced Pluripotent Stem Cell-derived cardiomyocytes
Online packet buffering
Modulation of electrical signal propagation in stem cell-derived cardiomyocytes as a novel model for arrhythmogenic cardiomyopathies
Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium
Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy
Pregnancy in arrhythmogenic cardiomyopathy
Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1
Mechanodynamics of cardiomyocytes in the context of dilated cardiomyopathy (DCM)
The impact of genotype on the cellular architecture of dilated and arrhythmogenic cardiomyopathies
Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes
Arrhythmogenic cardiomyopathy
Correction: Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes
Investigating LMNA-related dilated cardiomyopathy using human induced Pluripotent Stem Cell-derived cardiomyocytes
Online packet buffering
Modulation of electrical signal propagation in stem cell-derived cardiomyocytes as a novel model for arrhythmogenic cardiomyopathies
Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium
Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy